Cerulean Pharma Inc. Appoints Interim Chief Financial Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU) today announced the appointment of Gregg Beloff, J.D., M.B.A., as Interim Chief Financial Officer.
“Gregg brings extensive financial experience and leadership to Cerulean,” said Christopher D. T. Guiffre, President & Chief Executive Officer of Cerulean. “He has been the CFO of public and private life sciences companies and has a background in healthcare investment banking, so we will benefit from Gregg’s deep knowledge of the life sciences industry and from his experience in managing, growing and building finance organizations.”
Help employers find you! Check out all the jobs and post your resume.
“Gregg brings extensive financial experience and leadership to Cerulean,” said Christopher D. T. Guiffre, President & Chief Executive Officer of Cerulean. “He has been the CFO of public and private life sciences companies and has a background in healthcare investment banking, so we will benefit from Gregg’s deep knowledge of the life sciences industry and from his experience in managing, growing and building finance organizations.”
Help employers find you! Check out all the jobs and post your resume.